Status:
UNKNOWN
Relation Between Serum IGF-1 & BMI In Acne Vulgaris
Lead Sponsor:
Assiut University
Conditions:
Evaluation of Serum Level of Insulin Like Growth Factor 1
Eligibility:
All Genders
15-45 years
Brief Summary
cross-sectional study in which participants will be recruited at dermatology \& Andrology out-patient clinics in Assuit university hospital, Egypt after patients examination by dermatologists \& obtai...
Eligibility Criteria
Inclusion
- Patients aged from 15 to 45 years old suffering from acne vulgaris.
- Both sexes.
Exclusion
- Insulin resistance and diabetic patients
- Females with polycystic ovarian syndrome
- Treatment with drugs that can influence IGF-1level such as corticosteroid, insulin, hypoglycemic agents, and isotretinoin within one year before the date of study.
- Other causes of acne or acneform eruption as steroid-induced
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05301569
Start Date
April 1 2023
End Date
May 30 2024
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rania Sallam
Cairo, Qalubya, Egypt, 13772